✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change; this is a published study protocol with no results yet — findings will need to be awaited before any clinical implications can be drawn.
✦ Why It Matters ✦
Blood-based hormone biomarkers for vestibular disorders could eventually streamline diagnosis and enable personalised prognosis, addressing a field where objective diagnostic tools remain limited.
✦ Key Points ✦
- 01Prospective observational cohort study protocol published for a tertiary referral centre in Germany.
- 02Focus is on blood hormone biomarkers as diagnostic and prognostic tools for vestibular disorders.
- 03No results are available yet — this is a methods/protocol paper.
- 04The study targets a population where objective biomarkers are currently lacking.
- 05Findings, once available, could inform future clinical guidelines for vestibular diagnosis.
✦ Claims & Evidence ✦
ClaimEvidenceSupport
Blood hormone biomarkers may serve as diagnostic and prognostic tools in vestibular disorders.
studyunclear✦ Research metadata ✦
- PMID
- 42919589
- DOI
- 10.1136/bmjopen-2026-124215.
- Journal
- BMJ Open
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients with vestibular disorders attending a tertiary referral centre in Germany
- Intervention
- Blood hormone biomarker measurement
- Comparator
- Healthy controls or alternative diagnostic benchmarks (per protocol)
Primary outcomes
Diagnostic accuracy of blood hormone biomarkers for vestibular disorders; Prognostic value of blood hormone biomarkers for vestibular disorder outcomes